冠状动脉旁路移植术后二级预防：2026美国心脏协会科学声明更新
该科学声明由美国心脏协会发布，针对冠状动脉旁路移植术后患者二级预防的独特挑战，基于2015年声明后的新证据更新推荐，强调二级预防与术后结局改善强相关，旨在促进循证实践应用。
要点
- 搭桥术后冠心病仍进展，二级预防需应对弥漫病变、合并症及桥血管通畅性挑战
- 新声明更新2015年后证据，强调二级预防与术后结局改善强相关
- 应推动循证实践考量落地，提高二级预防措施的使用率
核心结论
- 冠状动脉旁路移植术后二级预防与结局改善强相关，需基于新证据更新实践推荐。
研究设计与样本
- 美国心脏协会发布科学声明，对2015年相关声明进行更新。
主要发现
- 搭桥术后冠心病继续进展，患者因冠状动脉病变严重弥漫、术后恢复复杂、合并症负担重而面临二级预防独特挑战。
- 确保长期桥血管通畅和防止疾病进一步进展是术后管理重点。
- 2015年声明以来二级预防策略出现新证据和进展。
临床怎么用
- 应促进循证实践考量并提高二级预防措施在搭桥术后的使用。
以上解读依据论文摘要（全文未开放获取或许可不允许翻译转载）。
原文
Coronary artery bypass grafting is a well-established, durable, and safe surgical intervention. However, coronary artery disease continues to progress after the procedure. Patients who have undergone bypass surgery present unique challenges in terms of secondary prevention resulting from the often severe and diffuse nature of their coronary disease, the complexities of their postoperative recovery, the burden of their comorbid conditions, and the importance of ensuring long-term graft patency and preventing further disease progression. New evidence and advances in secondary prevention strategies in the post-coronary bypass grafting population have emerged since the American Heart Association's 2015 scientific statement on this topic. Secondary prevention strongly correlates with improved outcomes after bypass surgery, providing the rationale and urgency for this updated scientific statement to promote evidence-based practical considerations and to improve their use.
引用
- Ruel M, Sandner S, Ponnambalam M, et al. Secondary Prevention After Coronary Artery Bypass Graft Surgery: 2026 Update: A Scientific Statement From the American Heart Association. Circulation. 2026. PMID: 42125794. doi:10.1161/CIR.0000000000001434
供执业医师工作参考，不替代临床判断；数值与分级以指南原文为准。